Prothena's Q3 loss widened as revenues fell short of estimates, but its Alzheimer and Parkinson's drug programs gained FDA momentum and key collaborations advanced.

Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces ...

Scientists in Singapore have created one of the most detailed maps of the developing human brain. The team at Duke-NUS ...

A man who was diagnosed with Parkinson's five years ago days he has "got his life back" thanks to a prescription for medical cannabis. Steve Willis, 72, first spotted the warning signs of Parkinson's ...

Net cash used in operating and investing activities was $40.6 million and $140.4 million for the third quarter and first nine ...

For years, scientists have studied Parkinson’s but haven’t been able to figure out exactly what causes it. Without knowing ...

On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center ...

A policy which has seen Powys patients being forced to wait longer for treatment has been branded “a cruel and indefensible act of ...

Introduction Parkinson’s disease (PD) is a chronic neurodegenerative condition that affects approximately 10 million people worldwide. As the second most common neurodegenerative disease, its ...

A mathematical model reveals circadian rhythms' impact on medication efficacy, particularly for neurological conditions like Parkinson’s disease and depression. The model focuses on dopamine reuptake ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...

Summary: Scientists have built one of the most comprehensive single-cell maps of the developing human brain. The new BrainSTEM framework analyzed nearly 680,000 fetal brain cells to chart their growth ...